PPD, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PPD, Inc. - overview
Established
1985
Location
Wilmington, NC, US
Primary Industry
Pharmaceuticals
About
Founded in 1985 and based in North Carolina, US, PPD, Inc. , formerly Pharmaceutical Product Development, LLC operates as a drug discovery and development firm providing its services to pharmaceutical, biotech, medical device, and government organizations. In December 2021, the firm raised USD 1. 62 billion in an IPO, selling 60 million shares at USD 27 per share on the Nasdaq Global Select Market stock exchange.
<br /><br />In June 2020, GHO Capital acquired X-Chem Pharmaceuticals from Pharmaceutical Product Development, LLC. <br /><br />In September 2020, PPD, Inc. issued an additional 38 million shares on the Nasdaq Global Select Market stock exchange for USD 32. 25 per share.
The transaction is valued at USD 1. 37 billion. <br /><br />In April 2021, Thermo Fisher Scientific Inc. agreed to acquire full ownership of PPD, Inc.
from Carlyle Group and Hellman & Friedman for USD 17. 4 billion in cash, or for USD 47. 50 per share, generating a multiple of 8. 5x.
The deal was completed in December 2021. The deal was completed in December 2021. In addition, Thermo Fisher will assume approximately USD 3. 5 billion of net debt.
To fund the transaction, Thermo Fisher intends to use proceeds from debt financing and cash on hand. The deal values the company at USD 21 billion. The company offers a variety of services including biostatistics, medical research, laboratories, data management, and consulting services. The company assists customers in providing therapies to patients by expediting the time of drug development and reducing costs.
Primary Industry
Pharmaceuticals
Sub Industries
Consulting Services, Bioinformatics, Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Therapeutic Devices, Pharmaceutical Research & Development
Website
www.ppd.com
Verticals
HealthTech
Company Stage
Acquired
Total Amount Raised
Subscriber access only
PPD, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | PPD, Inc. | - | ||||||||
| Private Placement/Follow on | Completed | PPD, Inc. | - | ||||||||
| Secondary Buyout | Completed | X-Chem, Inc. | - | ||||||||
| IPO | Completed | PPD, Inc. | - | ||||||||
| Add-on, Trade Sale | Completed | BioClinica Inc.'s Clinical Research Site Business | - |
Displaying 1 - 5 of 11
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.